A Study to Identify Microbiome Markers Associated with Preterm Labor

Overview

About this study

The purpose of this study is to identify components of the vaginal microbiology environment that contribute to the occurance of preterm labor and preterm delivery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Age ≥ 18
  • Ability to provide written informed consent
  • Willingness to participate in the mandatory translational research component of the study
  • Pregnant

Exclusion Criteria

  • Known immunodeficiency
  • Chronic, active viral infections, including HIV-1/2, HTLV-1/2, hepatitis B/C
  • Known autoimmune disease (e.g., rheumatoid arthritis or systemic lupus erythematosus)
  • Solid organ or transplant recipient
  • Multiple gestations
  • Oral or IV antibiotic treatment within the last 4 weeks
  • Known uterine anomalies
  • Evaluation following trauma event

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Margaret Dow, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions